Companies › Eli Lilly › Operating cash flow

Eli Lilly operating cash flow, 2008–2025

Eli Lilly reported operating cash flow of $16.8 billion for the fiscal year ended Dec. 31, 2025, up 90.7% from $8.82 billion the year before, according to its Form 10-K.

$16.8Blatest fiscal year (ended Dec. 31, 2025)
+90.7%change from the year before
$16.8Bhighest year shown (2025)
2008: $7.30B ’08 2009: $4.34B 2010: $6.86B ’10 2011: $7.23B 2012: $5.30B ’12 2013: $5.74B 2014: $4.46B ’14 2015: $2.96B 2016: $4.85B ’16 2017: $5.62B 2018: $5.52B ’18 2019: $4.84B 2020: $6.50B ’20 2021: $7.37B 2022: $7.59B ’22 2023: $4.24B 2024: $8.82B ’24 2025: $16.8B ’25

Fiscal years labeled by the year in which they ended. Bars drawn from the table below.

Eli Lilly operating cash flow by fiscal year

Fiscal year endedOperating cash flowChangeFiling
Dec. 31, 2025 $16.8B +90.7% 10-K (2026) ↗
Dec. 31, 2024 $8.82B +108.0% 10-K (2026) ↗
Dec. 31, 2023 $4.24B −44.1% 10-K (2026) ↗
Dec. 31, 2022 $7.59B +3.0% 10-K (2025) ↗
Dec. 31, 2021 $7.37B +13.3% 10-K (2024) ↗
Dec. 31, 2020 $6.50B +34.4% 10-K (2023) ↗
Dec. 31, 2019 $4.84B −12.5% 10-K (2022) ↗
Dec. 31, 2018 $5.52B −1.6% 10-K (2021) ↗
Dec. 31, 2017 $5.62B +15.8% 10-K (2020) ↗
Dec. 31, 2016 $4.85B +63.6% 10-K (2019) ↗
Dec. 31, 2015 $2.96B −33.5% 10-K (2018) ↗
Dec. 31, 2014 $4.46B −22.3% 10-K (2017) ↗
Dec. 31, 2013 $5.74B +8.1% 10-K (2016) ↗
Dec. 31, 2012 $5.30B −26.7% 10-K (2015) ↗
Dec. 31, 2011 $7.23B +5.5% 10-K (2014) ↗
Dec. 31, 2010 $6.86B +58.2% 10-K (2013) ↗
Dec. 31, 2009 $4.34B −40.6% 10-K (2012) ↗
Dec. 31, 2008 $7.30B — 10-K (2011) ↗

Other Eli Lilly financials

RevenueNet incomeDiluted EPSR&D expenseDividends per shareDiluted sharesTotal assetsCash and equivalentsStockholders' equity Quarterly results and next earnings date Eli Lilly company hub

FAQ

Q What was Eli Lilly's operating cash flow in its latest fiscal year?

A Eli Lilly reported operating cash flow of $16.8 billion for the fiscal year ended Dec. 31, 2025, up 90.7% from $8.82 billion the year before, according to its Form 10-K.

Q What is Eli Lilly's highest annual operating cash flow on record here?

A $16.8 billion, in the fiscal year ended Dec. 31, 2025, among the fiscal years 2008–2025 reported in its 10-K XBRL data.

Q Where does this operating cash flow data come from?

A From Eli Lilly's annual reports on Form 10-K, as tagged in XBRL and published by the SEC (company facts). Net cash provided by (used in) operating activities, from the cash flow statement.

Source: Eli Lilly's annual reports on Form 10-K via SEC XBRL company facts, updated Oct. 15, 2026. Net cash provided by (used in) operating activities, from the cash flow statement. For each year the most recent 10-K that reports it is used, so a figure a company later restated shows the restated value; the filing link shows which report it came from. Change is our arithmetic. Financial data, not investment advice.